Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04405297 · ClinicalTrials.gov registry record
A Disease-based Treatment Study for Diagnosed Osteoarthritis Utilizing Adipose-derived Regenerative Cells
A clinical trial, sponsored by Sanford Health.
- Terminated
- Registry status
- 14
- Enrollment target
NCT04405297 is a clinical trial that was terminated before completion, run by Sanford Health. The registered enrollment target is 14 participants.
The verdict
NCT04405297 was terminated before completion, sponsored by Sanford Health.
- TERMINATED
- Registry status
- 14 participants
- Enrollment target
Study Summary
This is a prospective, multi-location safety and effectiveness study, and data registry of autologous adult ADRCs generated by the Transpose® RT System in subjects with OA in the shoulder, wrist, knee, hip, or ankle.
Interventions
- DEVICE Adipose-derived regenerative cells
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2021-05-24 |
| Est. Completion | 2024-09-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04405297
The ClinicalTrials.gov registry entry for NCT04405297 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sanford Health, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Adipose-derived regenerative cells is the first listed.
NCT04405297 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04405297 about?
NCT04405297 is a clinical study titled "A Disease-based Treatment Study for Diagnosed Osteoarthritis Utilizing Adipose-derived Regenerative Cells". This is a prospective, multi-location safety and effectiveness study, and data registry of autologous adult ADRCs generated by the Transpose® RT System in subjects with OA in the shoulder, wrist, knee, hip, or ankle.
What is the current status of trial NCT04405297?
This trial is currently terminated. The enrollment target is 14 participants. The study started on 2021-05-24. Estimated completion is 2024-09-23.
What interventions are being tested in trial NCT04405297?
The interventions under investigation include: Adipose-derived regenerative cells (DEVICE).
Who is sponsoring clinical trial NCT04405297?
This trial is sponsored by Sanford Health, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.